Things to Consider When Selecting Patients
Things to Consider When Selecting Patients
Having patients be part of your clinical study planning can provide important insights. Carefully selecting patient partners is a critical step to obtaining meaningful patient insights. Consider the following patient criteria when evaluating the types of patients to best support your needs:
- Your access to patients (via patient groups, patient advocates) or need to engage with a third-party vendor
- Need to engage with caregivers in addition to/instead of patients
- Where patients are in their patient journey (influencers, family dynamics, community)
- Variety of treatment experience
- Disease state/co-morbidities
- Diversity (demographics, education, literacy levels, socioeconomic backgrounds, geography, language)
- Perception of clinical studies specific to the patient population
- A mix of naïve and experienced patients/advocates to create a comprehensive voice
- Patients with varying degrees of exposure to/involvement in clinical studies
What Type of Patient Engagement Method Will Help Achieve the Objective(s)?
Consider the internal budget and timelines. Consider the outcome you hope to gain to help determine meeting type
- Direct vs. indirect patient engagement:
- Will third-party moderator be utilized or will sponsor company to facilitate and lead?
- Sponsor name may be preferred to be kept anonymous to patients as to not create bias.
- Ensure all present are well prepared to have effective interactions with patients (e.g., with appropriate language and reactions).
- Regardless of the type of meeting, be sure to prepare engaging interactive activities to get patients comfortable discussing themselves and their condition
Consider having an experienced moderator/facilitator, as this is highly recommended for all meetings with patients Moderator/facilitator should be able to create a comfortable environment and should not use corporate jargon/acronyms Consider scheduling engagements so relevant sponsor team members can engage firsthand or observe the interactions with patients (e.g., regulatory, clinical development leads, operational lead, etc.)